-- Chiesi's abstract presentations will focus on clinical insights and patient-reported outcomes inFabry disease and alpha-mannosidosis -- -- These scientific contributions in lysosomal storage ...
-- These scientific contributions in lysosomal storage disorders (LSDs) underscore a sustained investment in data generation, patient-centered research, and authentic rare disease representation -- ...
Bank CEOs in Europe urged calm as stock markets in Europe, the U.S. and Asia tumbled into negative territory on Tuesday. Goldman Sachs International co-CEO Anthony Gutman told CNBC the volatility ...
Indonesian production company Forka Films has unveiled a production consortium for auteur Kamila Andini’s upcoming feature “Four Seasons in Java,” scheduled for 2026 release. The announcement came at ...
America’s energy system is at a critical juncture. The surge in electricity demand, driven by the explosive growth of artificial intelligence and data centers, is colliding with an aging and ...
Cloud service providers' procurement surges with global server shipments expected to rise 8% quarter-on-quarter in the third quarter of 2025 and exceed four million units in the fourth quarter.
The global environmental crisis is also a crisis of information. The destruction of forests, reefs, and rivers proceeds faster than our ability to explain it. Yet in many countries, the people best ...
src/ ├── main/ │ ├── java/ │ │ └── domus/global/challenge/ │ │ ├── application/ │ │ │ ├── controller/ # Controladores ...
Abstract: Global localization is an essential ingredient for autonomous mobile robots. However, existing global localization systems primarily rely on Global Navigation Satellite System (GNSS), ...
Java Films, a leading global documentary sales company based in Paris, France, has acquired world rights, excluding the countries of co-production (Ukraine, France and Belgium), as well as Czech TV ...
Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results